Salivary Cystatin C as a Biochemical Marker for Chronic Renal Failure
More details
Hide details
Department of chemistry, College of education, University of Samarra, IRAQ
Online publication date: 2018-09-16
Publication date: 2018-09-16
Eurasian J Anal Chem 2018;13(5):em52
A case control study was conducted on 49 subjects 29 of them with chronic renal disease and 20 subjects as control with age range between (45-75) years were investigated to determine the correlation of salivary and serum cystatin, urea and creatinine to assess their significance in the diagnoses of patients with chronic renal disease. The results indicated that the level of salivary cystatin was significantly (P ≤ 0.05) elevated in chronic renal disease (292.517±37.19 ng/ml) as compared to control (144.45±22.963 ng/ml). The level of serum cystatin was significantly (P ≤ 0.05) elevated in chronic renal disease (498.414±59.091 ng/ml) as compared to control (391.60±49.488ng/ml). The level of serum creatinine was significantly (P ≤ 0.05) elevated in chronic renal disease (4.369±0.799 mg/dl) as compared to control (1.007± 0.180 mg/dl). The level of urea was significantly (P ≤ 0.05) elevated in chronic renal disease (56.138±5.908 mg/dl) as compared to control (31.80 ± 5.176 mg/dl). From all the above results, we can conclude that salivary cystatin can be considered as a better biochemical marker for renal function compared to serum cystatin in chronic renal disease.
Keller CR, Odden MC, Fried LF, Newman AB, Angleman S, Green CA. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study. Kidney Int. 2007;71(3):239-44.
J Mareš D, Stejskal J, Vavroušková K, Urbánek R, Herzig P. Use of Cystatin C Determination in Clinical Diagnostics. Biomed. Papers. 2003;147(2):177–180.
Dharnidharka VR, Kwan C, Stevens G. Seram cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis. 2002;40(2):221-6.
Pallavi M. Estimation of Serum Cystatin C in Normal Healthy Population .Indo American Journal of Pharmaceutical Research, 2016;6(7).
Thomas R, Kanso A, Sedor JR. Chronic kidney disease and its complications. Prim Care. 2008;35(2):1-15.
Streckfus CF, Bigler LR. Saliva as a diagnostic fluid. Oral Dis. 2002;8:69–76.
Debora P. Salivary markers in patients with chronic renal failure. Archives of Oral Biology. 2015;60:1784–178.
Venktapathy R, Govindarajan V, Oza N, Parameswaran S, Dhanasekaran BP, Prashad KV. Salivary creatinine estimation as an alternative to serum creatinine in chronic kidney disease patnties. IJN. 2014;Article ID 742724, 6.
Abdulla HI, Al-Kotany MY, Mahdi KA. Assessment of oral manifestations of patients with renal failure undergoing hemodialysis by serum and salivary biomarkers. MDJ. 2012;9(1):118-29.
Narula AS. Chronic kidney disease. The looming threat. MJAFI. 2008;64(1):2-3.
Bagalad BS, Mohankumar KP, Madhushankari GS, Donoghue M, Kuberappa PH. Diagnostic accuracy of salivary creatinine, urea, and potassium levels to assess dialysis need in renal failure patients. Dent Res J. 2017;14:13-8.
Lasisi TJ, Raji YR, Salako BL. Salivary creatinine and urea analysis in patients with chronic kidney disease: a case control study. 2016;16(17):10. https://doi.rg/10.1186/s12882-....
Bader RS, Kora MA, El-Shalakany AH, Mashal BS. Clinical significance of saliva urea and creatinine levels in patients with chronic kidney disease. Menoufia Med J. 2015;28:406-10.
Divya P, Nagrajappa KS. Assessment and Correlation of Urea and Creatinine Levels in Saliva and Serum of Patients with Chronic Kidney Disease, Diabetes and Hypertension. A Research Study Journal of Clinical and Diagnostic Research. 2016;10(10):ZC58-ZC62.
Thomassen SA, Johannesen IL, Erlandsen EJ, Abrahamsen J, Randers E. Serum cystatin C as a marker of the renal function in patients with spinal cord injury. Spinal cord. 2002;40:524-528.
Gerbes L, Gülberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut. 2002;50(1):106–110.
Khorgami ZH, Abdollahi A, Soleimani S, Ahamadi F, Mahdavi-Mazdeh M. Relationship between Serum Cystatin C and Creatinine or Dialysis Adequacy in Patients on Chronic Maintenance Hemodialysis. Nephrourol Mon. 2013;5(2):733–735.
Alaraj M, Alaraj N, Tarek D. Hussein. Early Detection of Renal Impairment by Biomarkers Serum Cystatin C and Creatinine in Saudi Arabia. J Res MedDent Sci. 2017;5(1):37-45.
Turk V, Stoka V, Turk D. Cystatins: biochemical and structural properties, and medical relevance. Front Biosci. 2008;13(1):5406-5420.